Encision Inc (ECIA)

Healthcare | Medical Instruments Supplies
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 1,602,728 1,585,581 1,755,388 1,630,931
Cost of Revenue 724,269 735,291 926,906 688,268
Gross Profit 878,459 850,290 828,482 942,663
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 732,799 732,353 831,885 775,140
Operating Expenses 898,239 871,157 987,400 914,320
Operating Income -19,780 -20,867 -158,918 28,343
Interest Expense 18,009 9,508 10,598 6,369
Income Before Tax -41,133 -24,668 -170,262 22,041
Income Tax Expense 0 0 0 0
Net Income -41,133 -24,668 -170,262 22,041
Per Share
EPS 0.00 0.00 -0.01 0.00
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 6,555,315 6,585,882 7,349,000 7,668,000 7,537,834
Cost of Revenue 3,044,029 3,449,920 3,316,000 3,880,000 3,632,731
Gross Profit 3,511,286 3,135,962 4,033,000 3,788,000 3,905,103
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,090,114 3,154,851 3,520,000 3,465,000 3,397,202
Operating Expenses 3,683,266 3,776,745 4,336,000 4,383,000 3,966,744
Operating Income -171,980 -640,783 -303,000 -595,000 -61,641
Interest Expense 43,723 62,373 21,000 7,224 87,127
Income Before Tax -220,198 -691,783 -324,000 -66,000 584,734
Income Tax Expense 0 0 42,000 -529,340 0
Net Income -220,198 -691,783 -366,000 463,340 584,734
Per Share
EPS -0.02 -0.06 -0.03 0.04 0.05
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 257,433 42,509 189,000 950,000
Short Term Investments 0 0 0 0
Net Receivables 786,471 891,129 921,000 948,000
Inventory 1,483,182 1,402,338 1,899,000 1,584,000
Total Current Assets 2,612,765 2,426,274 3,125,000 3,602,000
Property Plant Equipment 813,152 1,154,791 799,000 975,000
Goodwill and Intangibles 171,890 164,010 163,000 181,000
Total Assets 3,670,699 3,810,716 4,134,000 4,792,000
Liabilities
Account Payables 346,900 346,049 253,000 576,000
Short Term Debt 870,490 569,256 575,000 384,000
Total Current Liabilities 1,575,915 1,220,022 1,131,000 1,276,000
Long Term Debt 443,682 763,946 508,000 770,000
Total Liabilities 2,019,597 1,983,968 1,639,000 2,046,000
Shareholders Equity
Retained Earnings -22,765,245 -22,545,047 -21,853,000 -21,529,000
Total Shareholders Equity 1,651,102 1,826,748 2,495,000 2,746,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 257,433 42,509 189,000 950,000 1,474,339
Short Term Investments 0 0 0 0 0
Net Receivables 786,471 891,129 921,000 948,000 1,024,370
Inventory 1,483,182 1,402,338 1,899,000 1,584,000 1,445,134
Total Current Assets 2,612,765 2,426,274 3,125,000 3,602,000 4,097,994
Property Plant Equipment 813,152 1,154,791 799,000 975,000 1,326,688
Goodwill and Intangibles 171,890 164,010 163,000 181,000 213,368
Total Assets 3,670,699 3,810,716 4,134,000 4,792,000 5,658,546
Liabilities
Account Payables 346,900 346,049 253,000 576,000 389,088
Short Term Debt 870,490 569,256 575,000 384,000 323,375
Total Current Liabilities 1,575,915 1,220,022 1,131,000 1,276,000 1,176,251
Long Term Debt 443,682 763,946 508,000 770,000 1,680,189
Total Liabilities 2,019,597 1,983,968 1,639,000 2,046,000 2,856,440
Shareholders Equity
Retained Earnings -22,765,245 -22,545,047 -21,853,000 -21,529,000 -21,463,725
Total Shareholders Equity 1,651,102 1,826,748 2,495,000 2,746,000 2,802,106
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -220,198 -691,783 -324,000 -66,000
Depreciation & Amortization 81,393 85,218 87,000 113,000
Stock Based Compensation 46,000 53,552 51,892 41,000
Change in Working Capital 32,936 685,402 -691,000 39,000
Operating Cash Flow -54,948 144,389 -861,000 -444,000
Investing Activities
Capital Expenditure -80,025 -36,823 -183,000 -36,000
Investments -54,415 -12,050 -183,000 -36,000
Investing Cash Flow -80,025 -36,823 -183,000 -36,000
Financing Activities
Debt Repayment 351,346 -224,190 -263,105 -13,000
Common Stock Issued/Repurchased -1,449 -29,833 21,000 -31,501
Dividends Paid 0 0 0 0
Financing Cash Flow 349,897 -254,023 284,000 -44,000
Summary
Free Cash Flow -134,973 107,566 -1,044,000 -480,000
Net Change in Cash 214,924 -146,457 -761,000 -524,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -220,198 -691,783 -324,000 -66,000 584,734
Depreciation & Amortization 81,393 85,218 87,000 113,000 88,955
Stock Based Compensation 46,000 53,552 51,892 41,000 33,354
Change in Working Capital 32,936 685,402 -691,000 39,000 159,905
Operating Cash Flow -54,948 144,389 -861,000 -444,000 219,946
Investing Activities
Capital Expenditure -80,025 -36,823 -183,000 -36,000 -45,186
Investments -54,415 -12,050 -183,000 -36,000 -30,020
Investing Cash Flow -80,025 -36,823 -183,000 -36,000 -45,186
Financing Activities
Debt Repayment 351,346 -224,190 -263,105 -13,000 -371,000
Common Stock Issued/Repurchased -1,449 -29,833 21,000 -31,501 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 349,897 -254,023 284,000 -44,000 914,447
Summary
Free Cash Flow -134,973 107,566 -1,044,000 -480,000 174,760
Net Change in Cash 214,924 -146,457 -761,000 -524,000 1,089,207